Genitourinary System Neoplasm — Trials

Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

17,388 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 251–300 of 478 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05271318	Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer.(PROTA)	active not recruiting	Phase 1 / Phase 2	29	TILT Biotherapeutics Ltd.INDUSTRY	2	May 5, 2026	clinicaltrials
NCT03393884	Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)(OVATION 2)	active not recruiting	Phase 1 / Phase 2	130	ImunonINDUSTRY